Center for Neurodegeneration and Experimental Therapeutics (CNET)
Established February 2, 2007, CNET promotes the discovery of novel treatments for neurodegenerative disorders, teaches scientists and clinicians about these diseases, and facilitates the application of these discoveries to clinical care of patients.
These neurodegenerative disorders include Alzheimer’s disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS, known as Lou Gehrig’s disease), and other less common neurodegenerative disorders that occur more frequently with advancing age. A common feature of these diseases is that in each there is selective premature death and malfunction of neurons in specific parts of the brain, which gives rise to the characteristic symptoms. At present there are treatments which can provide some temporary improvement of the symptoms of these diseases, but there are no treatments which can substantially slow the underlying brain degeneration.